Edition:
United Kingdom

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

3,981JPY
14 Dec 2018
Change (% chg)

¥1 (+0.03%)
Prev Close
¥3,980
Open
¥4,000
Day's High
¥4,028
Day's Low
¥3,955
Volume
11,583,700
Avg. Vol
6,307,831
52-wk High
¥6,693
52-wk Low
¥3,662

Select another date:

Wed, Dec 5 2018

Photo

Takeda clears key hurdle as investors back $59 billion Shire deal

OSAKA Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt. | Video

UPDATE 4-Takeda clears key hurdle as investors back $59 billion Shire deal

* Shares in Shire and Takeda both gain ground (Updates with approval from Shire shareholders)

Takeda investors back $59 billion Shire deal, but wary of debt load

OSAKA Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion (46.3 billion pounds) takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt. | Video

Takeda shareholders approve Shire acquisition - spokesman

TOKYO, Dec 5 Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, a Takeda spokesman said, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.

Investor advisory firms back Takeda's $62 billion deal for Shire

LONDON Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion (48 billion pounds) takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal.

EU approves Takeda buying Shire, on divestment condition

BRUSSELS The European Commission said on Tuesday that it approved the $62-billion (48.2 billion pounds) takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

EU approves Takeda buying Shire, on divestment condition

BRUSSELS The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

EU approves Takeda buying Shire, on divestment condition

BRUSSELS, Nov 20 The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development.

Investor advisory firms back Takeda's $62 billion deal for Shire

LONDON Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal.

Investor advisory firms back Takeda's $62 billion deal for Shire

LONDON, Nov 20 Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire, dealing a blow to a group of investors who hope to block the deal.

Select another date: